Cargando…
Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner
The innate immune response to cytosolic DNA involves transcriptional activation of type I interferons (IFN-I) and proinflammatory cytokines. This represents the culmination of intracellular signaling pathways that are initiated by pattern recognition receptors that engage DNA and require the adaptor...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360819/ https://www.ncbi.nlm.nih.gov/pubmed/32733475 http://dx.doi.org/10.3389/fimmu.2020.01430 |
_version_ | 1783559287993270272 |
---|---|
author | Abraham, Jinu Botto, Sara Mizuno, Nobuyo Pryke, Kara Gall, Bryan Boehm, Dylan Sali, Tina M. Jin, Haihong Nilsen, Aaron Gough, Michael Baird, Jason Chakhtoura, Marita Subra, Caroline Trautmann, Lydie Haddad, Elias K. DeFilippis, Victor R. |
author_facet | Abraham, Jinu Botto, Sara Mizuno, Nobuyo Pryke, Kara Gall, Bryan Boehm, Dylan Sali, Tina M. Jin, Haihong Nilsen, Aaron Gough, Michael Baird, Jason Chakhtoura, Marita Subra, Caroline Trautmann, Lydie Haddad, Elias K. DeFilippis, Victor R. |
author_sort | Abraham, Jinu |
collection | PubMed |
description | The innate immune response to cytosolic DNA involves transcriptional activation of type I interferons (IFN-I) and proinflammatory cytokines. This represents the culmination of intracellular signaling pathways that are initiated by pattern recognition receptors that engage DNA and require the adaptor protein Stimulator of Interferon Genes (STING). These responses lead to the generation of cellular and tissue states that impair microbial replication and facilitate the establishment of long-lived, antigen-specific adaptive immunity. Ultimately this can lead to immune-mediated protection from infection but also to the cytotoxic T cell-mediated clearance of tumor cells. Intriguingly, pharmacologic activation of STING-dependent phenotypes is known to enhance both vaccine-associated immunogenicity and immune-based anti-tumor therapies. Unfortunately, the STING protein exists as multiple variant forms in the human population that exhibit differences in their reactivity to chemical stimuli and in the intensity of molecular signaling they induce. In light of this, STING-targeting drug discovery efforts require an accounting of protein variant-specific activity. Herein we describe a small molecule termed M04 that behaves as a novel agonist of human STING. Importantly, we find that the molecule exhibits a differential ability to activate STING based on the allelic variant examined. Furthermore, while M04 is inactive in mice, expression of human STING in mouse cells rescues reactivity to the compound. Using primary human cells in ex vivo assays we were also able to show that M04 is capable of simulating innate responses important for adaptive immune activation such as cytokine secretion, dendritic cell maturation, and T cell cross-priming. Collectively, this work demonstrates the conceivable utility of a novel agonist of human STING both as a research tool for exploring STING biology and as an immune potentiating molecule. |
format | Online Article Text |
id | pubmed-7360819 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73608192020-07-29 Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner Abraham, Jinu Botto, Sara Mizuno, Nobuyo Pryke, Kara Gall, Bryan Boehm, Dylan Sali, Tina M. Jin, Haihong Nilsen, Aaron Gough, Michael Baird, Jason Chakhtoura, Marita Subra, Caroline Trautmann, Lydie Haddad, Elias K. DeFilippis, Victor R. Front Immunol Immunology The innate immune response to cytosolic DNA involves transcriptional activation of type I interferons (IFN-I) and proinflammatory cytokines. This represents the culmination of intracellular signaling pathways that are initiated by pattern recognition receptors that engage DNA and require the adaptor protein Stimulator of Interferon Genes (STING). These responses lead to the generation of cellular and tissue states that impair microbial replication and facilitate the establishment of long-lived, antigen-specific adaptive immunity. Ultimately this can lead to immune-mediated protection from infection but also to the cytotoxic T cell-mediated clearance of tumor cells. Intriguingly, pharmacologic activation of STING-dependent phenotypes is known to enhance both vaccine-associated immunogenicity and immune-based anti-tumor therapies. Unfortunately, the STING protein exists as multiple variant forms in the human population that exhibit differences in their reactivity to chemical stimuli and in the intensity of molecular signaling they induce. In light of this, STING-targeting drug discovery efforts require an accounting of protein variant-specific activity. Herein we describe a small molecule termed M04 that behaves as a novel agonist of human STING. Importantly, we find that the molecule exhibits a differential ability to activate STING based on the allelic variant examined. Furthermore, while M04 is inactive in mice, expression of human STING in mouse cells rescues reactivity to the compound. Using primary human cells in ex vivo assays we were also able to show that M04 is capable of simulating innate responses important for adaptive immune activation such as cytokine secretion, dendritic cell maturation, and T cell cross-priming. Collectively, this work demonstrates the conceivable utility of a novel agonist of human STING both as a research tool for exploring STING biology and as an immune potentiating molecule. Frontiers Media S.A. 2020-07-08 /pmc/articles/PMC7360819/ /pubmed/32733475 http://dx.doi.org/10.3389/fimmu.2020.01430 Text en Copyright © 2020 Abraham, Botto, Mizuno, Pryke, Gall, Boehm, Sali, Jin, Nilsen, Gough, Baird, Chakhtoura, Subra, Trautmann, Haddad and DeFilippis. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Abraham, Jinu Botto, Sara Mizuno, Nobuyo Pryke, Kara Gall, Bryan Boehm, Dylan Sali, Tina M. Jin, Haihong Nilsen, Aaron Gough, Michael Baird, Jason Chakhtoura, Marita Subra, Caroline Trautmann, Lydie Haddad, Elias K. DeFilippis, Victor R. Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner |
title | Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner |
title_full | Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner |
title_fullStr | Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner |
title_full_unstemmed | Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner |
title_short | Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner |
title_sort | characterization of a novel compound that stimulates sting-mediated innate immune activity in an allele-specific manner |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360819/ https://www.ncbi.nlm.nih.gov/pubmed/32733475 http://dx.doi.org/10.3389/fimmu.2020.01430 |
work_keys_str_mv | AT abrahamjinu characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT bottosara characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT mizunonobuyo characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT prykekara characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT gallbryan characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT boehmdylan characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT salitinam characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT jinhaihong characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT nilsenaaron characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT goughmichael characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT bairdjason characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT chakhtouramarita characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT subracaroline characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT trautmannlydie characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT haddadeliask characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner AT defilippisvictorr characterizationofanovelcompoundthatstimulatesstingmediatedinnateimmuneactivityinanallelespecificmanner |